Excitatory Amino Acid Antagonists
"Excitatory Amino Acid Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
Descriptor ID |
D018691
|
MeSH Number(s) |
D27.505.519.625.190.300 D27.505.696.577.190.300
|
Concept/Terms |
Excitatory Amino Acid Antagonists- Excitatory Amino Acid Antagonists
- Antagonists, Excitatory Amino Acid
- Amino Acids, Excitatory, Antagonists
- Glutamate Receptor Antagonists
- Antagonists, Glutamate Receptor
- Receptor Antagonists, Glutamate
- EAA Antagonists
- Antagonists, EAA
- Glutamate Antagonists
- Antagonists, Glutamate
- Amino Acid Antagonists, Excitatory
|
Below are MeSH descriptors whose meaning is more general than "Excitatory Amino Acid Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Excitatory Amino Acid Antagonists".
This graph shows the total number of publications written about "Excitatory Amino Acid Antagonists" by people in this website by year, and whether "Excitatory Amino Acid Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 1 | 2 |
1997 | 3 | 2 | 5 |
1998 | 0 | 2 | 2 |
1999 | 0 | 2 | 2 |
2000 | 1 | 3 | 4 |
2001 | 0 | 5 | 5 |
2002 | 0 | 1 | 1 |
2003 | 1 | 5 | 6 |
2004 | 0 | 2 | 2 |
2005 | 1 | 8 | 9 |
2006 | 2 | 5 | 7 |
2007 | 1 | 4 | 5 |
2008 | 4 | 6 | 10 |
2009 | 1 | 4 | 5 |
2010 | 1 | 2 | 3 |
2011 | 1 | 0 | 1 |
2012 | 3 | 2 | 5 |
2013 | 1 | 4 | 5 |
2014 | 1 | 2 | 3 |
2015 | 1 | 2 | 3 |
2017 | 0 | 3 | 3 |
2018 | 0 | 2 | 2 |
2020 | 2 | 0 | 2 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Excitatory Amino Acid Antagonists" by people in Profiles.
-
Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium. Expert Opin Drug Saf. 2021 Feb; 20(2):123-138.
-
Negative allosteric modulation of GluN1/GluN3 NMDA receptors. Neuropharmacology. 2020 10 01; 176:108117.
-
Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020 05 01; 180(5):728-736.
-
Endocrine Conditions in Older Adults: Menopause. FP Essent. 2018 Nov; 474:20-27.
-
Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy. Proc Natl Acad Sci U S A. 2018 Mar 27; 115(13):E3007-E3016.
-
Ketamine for the Acute Management of Excited Delirium and Agitation in the Prehospital Setting. Pharmacotherapy. 2018 01; 38(1):139-151.
-
Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats. Pharmacol Biochem Behav. 2017 Oct; 161:13-21.
-
Accumbens nNOS Interneurons Regulate Cocaine Relapse. J Neurosci. 2017 01 25; 37(4):742-756.
-
Altered NMDA receptor function in primary cultures of hippocampal neurons from mice lacking the Homer2 gene. Synapse. 2016 Jan; 70(1):33-9.
-
Reversal of alcohol dependence-induced deficits in cue-guided behavior via mGluR2/3 signaling in mice. Psychopharmacology (Berl). 2016 Jan; 233(2):235-42.